Dr. Elizabeth Thompson holds a PhD in pharmacy from the University of Saskatchewan, specializing in cannabinoid science with a focus on concussion, neuroinflammation, and pain, along with an MSc in Applied Physiology from the University of Texas and a BSc (Honours) in Molecular Biology from the University of Waterloo. With more than 20 years of experience in professional contact sports, she brings a deep understanding of athlete performance, safety, longevity, and the influence of sponsorships, league policies, and post-retirement health challenges. Her academic and professional background led her to investigate molecular pathways underlying concussion and neuroinflammation influenced by both endogenous and plant-derived cannabinoids. As part of a Canadian research team funded by the NFL and NFL Players Association, she is currently involved in a multi-site clinical trial examining the pharmacokinetics and therapeutic potential of cannabinoids for pain management, brain health, and quality of life in athletes. She has published in journals including Sports Medicine Journal, BMC Neurology, and Sports, and she leads Train With Mary Jane, a multimedia education platform that translates complex cannabinoid science into accessible content for athletes, medical professionals, and the public. Through her combined research and outreach efforts, she aims to bridge cutting-edge science with real-world application, empowering informed decision-making around one of today’s most polarizing plant-based therapies.